FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Panicucci Rick
2. Issuer Name and Ticker or Trading Symbol

Q BioMed Inc. [ QBIO ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

366 MADISON STREET, 3RD FLOOR
3. Date of Earliest Transaction (MM/DD/YYYY)

2/13/2018
(Street)

NEW YORK, NY 10017
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 4/2/2018  A  1500 A (1)6000 D  
Common Stock 7/12/2018  A  1500 A (1)7500 D  
Common Stock 11/16/2018  A  2500 A (1)10000 D  
Common Stock 1/4/2019  A  1000 A (1)11000 D  
Common Stock 4/9/2019  A  1500 A (1)12500 D  
Common Stock 5/31/2019  A  500 A (1)13000 D  
Common Stock 8/28/2019  A  2000 A (1)15000 D  
Common Stock 10/9/2019  A  500 A (1)15500 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Incentive Stock Options $3 2/13/2018  A   37500     (2)2/13/2023 Common Stock 37500  (1)50000 D  
Incentive Stock Options $1.25 6/5/2018  A   150000     (3)6/5/2023 Common Stock 150000  (1)200000 D  
Incentive Stock Options $1.25 6/5/2019  A   150000     (4)6/5/2024 Common Stock 150000  (1)350000 D  

Explanation of Responses:
(1) Issued for director services.
(2) The options vest in 3 equal installments of 12,500 each, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. The first installment vested on August 13, 2018.
(3) The options vest in 4 equal installments of 37,500 each, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. The first installment vested on June 5, 2018.
(4) The options vest in 4 equal installments of 37,500 each, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. The first installment vested on June 5, 2019.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Panicucci Rick
366 MADISON STREET
3RD FLOOR
NEW YORK, NY 10017
X



Signatures
Rick Panicucci11/12/2019
**Signature of Reporting PersonDate

Q BioMed (CE) (USOTC:QBIO)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Q BioMed (CE) Charts.
Q BioMed (CE) (USOTC:QBIO)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Q BioMed (CE) Charts.